Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Vlachopoulos, C., Ioakeimidis, N., Terentes-Printzios, D
Regular physical activity supports GLP-1 production, improves insulin sensitivity, and produces weight loss benefits that compound over time
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
Medical Disclaimer This content is for informational purposes only and does not provide medical advice, diagnosis, or treatment
To maximize the benefits of semaglutide, we recommend integrating specific lifestyle changes tailored to your individual needs
